logo 5241 0.5 mg
Pill imprint logo 5241 0.5 mg has been identified as Anagrelide hydrochloride 0.5 mg.
Anagrelide is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous uncategorized agents. Risk cannot be ruled out during pregnancy.
Anagrelide 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Anagrelide hydrochloride Images
- Imprint:
-
logo 5241
0.5 mg - Strength:
- 0.5 mg
- Color:
- Gray / White
- Size:
- 14.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
crospovidone
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
ferrosoferric oxide
gelatin
lactose anhydrous
lactose monohydrate
magnesium stearate
povidone
propylene glycol
titanium dioxide
- Drug Class:
- Miscellaneous uncategorized agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-5241
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5443 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Anagrelide Hydrochloride resources
- Anagrelide (Wolters Kluwer)
- anagrelide (Cerner Multum)
- anagrelide (Micromedex) - Includes Dosage Information
- Anagrelide hydrochloride (AHFS DI)
- Anagrelide (FDA)
- Anagrelide (Wolters Kluwer)
Search Again
